LOS ANGELES — The case against Lance Armstrong is closed. His legacy as a seven-time Tour de France champion endures.
Federal prosecutors dropped their investigation of Armstrong on Friday, ending a nearly two-year effort aimed at determining whether the world's most famous cyclist and his teammates joined in a doping program during his greatest years.
Armstrong steadfastly has denied he doped during his unparalleled career, but the possibility of criminal charges threatened to stain not only his accomplishments, but his cancer charity work as well. Instead, another attempt to prove a star athlete used performance-enhancing drugs has fallen short, despite years of evidence gathering across two continents.
"I am gratified to learn that the U.S. Attorney's Office is closing its investigation," Armstrong said in a statement. "It is the right decision and I commend them for reaching it. I look forward to continuing my life as a father, a competitor, and an advocate in the fight against cancer without this distraction."
The probe, anchored in Los Angeles where a grand jury was presented evidence by federal prosecutors and heard testimony from Armstrong's former teammates and associates, began with a separate investigation of Rock Racing, a cycling team owned by fashion entrepreneur Michael Ball.
U.S. Attorney André Birotte Jr. announced in a press release that his office "is closing an investigation into allegations of federal criminal conduct by members and associates of a professional bicycle racing team owned in part by Lance Armstrong."
He didn't disclose the reason for the decision, though Birotte has used discretion in pursing high-profile criminal cases before. Last February, his office closed an investigation of mortgage giant Countrywide Financial Corp.
The pronouncement comes after a pair of less-than-successful cases against top sports figures accused of doping. Home run king Barry Bonds was found guilty of obstruction of justice and sentenced in December to 30 days' home detention — a conviction he's appealing — but prosecutors were unable to convince a jury he lied about using steroids. Roger Clemens' steroid trial is slated for April 17 after a judge declared a mistrial last summer when prosecutors showed jurors inadmissible evidence.
Investigators looked at whether a doping program was established for Armstrong's team while, at least part of the time, it received government sponsorship from the U.S. Postal Service. Authorities also examined whether Armstrong encouraged or facilitated doping on the team. He won the Tour de France every year from 1999-2005.
The hurdle for prosecutors wasn't so much to prove whether any particular cyclist used drugs, but to determine if Armstrong and other team members violated federal conspiracy, fraud or racketeering charges. Unlike Bonds and Clemens, who testified before a federal grand jury and Congress, respectively, and were accused of lying under oath, Armstrong was not questioned in front of the grand jury.
Betsy Andreu, who with her husband and former Armstrong teammate, Frank, accused the cycling champion of doping, said she was shocked by Birotte's decision.
"Our legal system failed us," she said. "This is what happens when you have a lot of money and you can buy attorneys who have people in high places in the Department of Justice."
Led by federal agent Jeff Novitzky, who also investigated Bonds and Clemens, U.S. authorities sought assistance overseas, requesting urine samples of U.S. Postal riders from France's anti-doping agency and also meeting with officials from Belgium, Spain and Italy.
Prosecutors also subpoenaed Armstrong supporters and ex-teammates to testify in Los Angeles. Among them were Ukrainian cyclist Yaroslav Popovych, who rode on three Armstrong teams dating back to 2005; Allen Lim, an exercise physiologist for Team Radioshack; and longtime Armstrong friend Stephanie McIlvain.
The investigation began after Novitzky was told about a cache of PEDs found by a landlord in the vacated apartment of Kyle Leogrande, a cyclist who rode for Rock Racing and had a doping ban, according to several people familiar with the case.
The case also was spurred by disgraced cyclist Floyd Landis, who claims Armstrong had a long-running doping system in place while they were teammates. Landis, who was stripped of the 2006 Tour de France title for drug use, acknowledged in 2010 he used performance-enhancing drugs after years of denying he cheated.
One of the most serious accusations came during a "60 Minutes" interview last May when former teammate Tyler Hamilton said he saw Armstrong use EPO during the 1999 Tour de France and in preparation for the 2000 and 2001 tours.
The report also said Armstrong loyalist George Hincapie, another ex-teammate, told federal authorities that he and Armstrong supplied each other with PEDs and discussed them. Hincapie released a statement after the segment aired, saying he did not speak with the show and didn't know where it got its information.
U.S. anti-doping officials said Friday they will not be dissuaded by the government's decision to close the Armstrong probe.
"Unlike the U.S. Attorney, USADA's job is to protect clean sport rather than enforce specific criminal laws," said Travis Tygart, chief executive officer of the U.S. Anti-Doping Agency. "Our investigation into doping in the sport of cycling is continuing and we look forward to obtaining the information developed during the federal investigation."
As the investigation progressed, Armstrong assembled a legal team, hired a spokesman and briefly created a website to address any of the allegations reported by the media.
Frustrated by a slew of news articles about the investigation, Armstrong's attorneys filed a motion in July, asking a judge to order federal agents to testify about their contacts with reporters.
Armstrong consciously maintained a high profile throughout the investigation, raising money for his cancer charity, Livestrong, and racing in events such as off-road triathlons. He had no reason to hide, he said.
A spokeswoman for Livestrong, Katherine McLane, said the group was "very glad to hear this news." She called Armstrong an inspiration to millions of cancer survivors.
That could have played a role in prosecutors' decision, one expert said.
"The government always has a tremendous amount of prosecutorial discretion regarding whether or not to bring an indictment. In this case it appears that they have acted judiciously and likely considered all of the good works of Lance Armstrong and his foundation," said Mathew Rosengart, a former federal prosecutor who is not involved in the case.
Associated Press writers Pete Yost in Washington, Anthony McCartney in Los Angeles and Eddie Pells in Las Vegas contributed to this report.